{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T10:30:11Z","timestamp":1788604211352,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.pntd.0010682","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000}}],"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>\n                    In June 2021, the World Health Organization (WHO), recognizing the need for new diagnostics to support the control and elimination of onchocerciasis, published the target product profiles (TPPs) of new tests that would support the two most immediate needs: (a) mapping onchocerciasis in areas of low prevalence and (b) deciding when to stop mass drug administration programs. In both instances, the test should ideally detect an antigen specific for live, adult\n                    <jats:italic>O<\/jats:italic>\n                    .\n                    <jats:italic>volvulus<\/jats:italic>\n                    female worms. The preferred format is a field-deployable rapid test. For mapping, the test needs to be \u2265 60% sensitive and \u2265 99.8% specific, while to support stopping decisions, the test must be \u2265 89% sensitive and \u2265 99.8% specific. The requirement for extremely high specificity is dictated by the need to detect with sufficient statistical confidence the low seroprevalence threshold set by WHO. Surveys designed to detect a 1\u20132% prevalence of a given biomarker, as is the case here, cannot tolerate more than 0.2% of false-positives. Otherwise, the background noise would drown out the signal. It is recognized that reaching and demonstrating such a stringent specificity criterion will be challenging, but test developers can expect to be assisted by national governments and implementing partners for adequately powered field validation.\n                  <\/jats:p>","DOI":"10.1371\/journal.pntd.0010682","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T13:40:48Z","timestamp":1659534048000},"page":"e0010682","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6870-6283","authenticated-orcid":true,"given":"Marco A.","family":"Biamonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Cantey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaya I.","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Gass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Hamill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Lammie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kamgno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Nutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Oguttu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieudonn\u00e9 P.","family":"Sankara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma A.","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Unnasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"pntd.0010682.ref001","unstructured":"WHO. Ending the Neglect to Attain the Sustainable Development Goals. A road map for neglected tropical diseases 2021\u20132030.2020. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240010352."},{"issue":"2","key":"pntd.0010682.ref002","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/trstmh\/traa118","article-title":"Diagnostics and the neglected tropical diseases roadmap: setting the agenda for 2030","volume":"115","author":"AA Souza","year":"2021","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0010682.ref003","author":"WHO","year":"2021","journal-title":"Diagnostic test for lymphatic filariasis to support decisions for stopping triple-therapy mass drug administration: target product profile"},{"key":"pntd.0010682.ref004","author":"WHO","year":"2021","journal-title":"Diagnostic test for surveillance of lymphatic filariasis: target product profile"},{"key":"pntd.0010682.ref005","author":"WHO","year":"2021","journal-title":"Onchocerciasis: diagnostic target product profile to support preventive chemotherapy"},{"key":"pntd.0010682.ref006","author":"WHO","year":"2021","journal-title":"Diagnostic target product profiles for monitoring, evaluation and surveillance of schistosomiasis control programmes."},{"key":"pntd.0010682.ref007","author":"WHO","year":"2021","journal-title":"Diagnostic target product profile for monitoring and evaluation of soil-transmitted helminth control programmes"},{"key":"pntd.0010682.ref008","unstructured":"WHO. WHO Target Product Profiles, Preferred Product Characteristics, and Target Regimen Profiles: Standard Procedure. Version 1.0. 2019."},{"key":"pntd.0010682.ref009","unstructured":"WHO. Onchocerciasis Fact Sheet. 2019. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/onchocerciasis."},{"issue":"10159","key":"pntd.0010682.ref010","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD Disease","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"pntd.0010682.ref011","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa206","article-title":"A Second Population-Based Cohort Study in Cameroon Confirms the Temporal Relationship Between Onchocerciasis and Epilepsy.","volume":"7","author":"CB Chesnais","year":"2020","journal-title":"Open Forum Infect Dis."},{"key":"pntd.0010682.ref012","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1017\/gmh.2019.24","article-title":"Nodding syndrome research, lessons learned from the NSETHIO project.","volume":"6","author":"D Geelhand de Merxem","year":"2019","journal-title":"Glob Ment Health (Camb)."},{"issue":"1","key":"pntd.0010682.ref013","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40249-018-0400-0","article-title":"Report of the first international workshop on onchocerciasis-associated epilepsy.","volume":"7","author":"R Colebunders","year":"2018","journal-title":"Infect Dis Poverty."},{"key":"pntd.0010682.ref014","unstructured":"WHO. Elimination of human onchocerciasis: progress report, 2019\u20132020. Weekly Epidemiological Record [Internet]. 2020; 95:[545\u201354 pp.]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/336417."},{"issue":"2","key":"pntd.0010682.ref015","doi-asserted-by":"crossref","first-page":"e0009064","DOI":"10.1371\/journal.pntd.0009064","article-title":"Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis.","volume":"15","author":"S Jawahar","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"pntd.0010682.ref016","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1007\/s00436-021-07307-4","article-title":"Onchocerciasis drug development: from preclinical models to humans","volume":"120","author":"A Ngwewondo","year":"2021","journal-title":"Parasitol Res"},{"issue":"4","key":"pntd.0010682.ref017","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/acsinfecdis.9b00469","article-title":"Macrofilaricides: An Unmet Medical Need for Filarial Diseases.","volume":"6","author":"NA Hawryluk","year":"2020","journal-title":"ACS Infect Dis."},{"key":"pntd.0010682.ref018","unstructured":"WHO. Conceptual and Operational Framework of Onchocerciasis Elimination with Ivermectin Treatment. 2010. Available from: https:\/\/www.who.int\/apoc\/oncho_elimination_report_english.pdf?ua=1."},{"issue":"4","key":"pntd.0010682.ref019","first-page":"655","article-title":"[Epidemiologic status of onchocerciasis].","volume":"57","author":"A Prost","year":"1979","journal-title":"Bull World Health Organ"},{"issue":"Suppl 1","key":"pntd.0010682.ref020","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1179\/000349802125000637","article-title":"Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC).","volume":"96","author":"M Noma","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"pntd.0010682.ref021","article-title":"WHO Programme for the Prevention of Blindness & UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases.","author":"P Ngoumou","year":"1993","journal-title":"A manual for rapid epidemiological mapping of onchocerciasis."},{"key":"pntd.0010682.ref022","article-title":"UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases.","author":"WHO","year":"1998","journal-title":"Guidelines for analysis of REMO data using GIS."},{"key":"pntd.0010682.ref023","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1756-3305-7-326","article-title":"The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.","volume":"7","author":"HG Zoure","year":"2014","journal-title":"Parasit Vectors."},{"issue":"2","key":"pntd.0010682.ref024","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.trstmh.2007.10.009","article-title":"Diagnostic value of nodule palpation in onchocerciasis","volume":"102","author":"HP Duerr","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9","key":"pntd.0010682.ref025","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/cid\/ciz172","article-title":"Loa loa Microfilariae in Skin Snips: Consequences for Onchocerciasis Monitoring and Evaluation in L. loa-Endemic Areas","volume":"69","author":"HC Nana-Djeunga","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pntd.0010682.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2883-4-1","article-title":"Frequent detection of worm movements in onchocercal nodules by ultrasonography.","volume":"4","author":"S Mand","year":"2005","journal-title":"Filaria J."},{"issue":"1","key":"pntd.0010682.ref027","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-3156.2006.01750.x","article-title":"Evaluation of the diethylcarbamazine patch to evaluate onchocerciasis endemicity in Central Africa.","volume":"12","author":"G Ozoh","year":"2007","journal-title":"Trop Med Int Health"},{"key":"pntd.0010682.ref028","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s13071-015-1122-9","article-title":"Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.","volume":"8","author":"K Awadzi","year":"2015","journal-title":"Parasit Vectors."},{"issue":"7","key":"pntd.0010682.ref029","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1371\/journal.pntd.0000497","article-title":"Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.","volume":"3","author":"L Diawara","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010682.ref030","article-title":"Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis.","author":"WHO","year":"2016","journal-title":"Criteria and procedures"},{"issue":"4","key":"pntd.0010682.ref031","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4269\/ajtmh.18-0132","article-title":"Evaluation of an OV-16 IgG4 Enzyme-Linked Immunosorbent Assay in Humans and Its Application to Determine the Dynamics of Antibody Responses in a Non-Human Primate Model of Onchocerca volvulus Infection","volume":"99","author":"VA Cama","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"pntd.0010682.ref032","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4269\/ajtmh.18-0341","article-title":"Operational Performance of the Onchocerca volvulus \"OEPA\" Ov16 ELISA Serological Assay in Mapping, Guiding Decisions to Stop Mass Drug Administration, and Posttreatment Surveillance Surveys.","volume":"99","author":"FO Richards","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0010682.ref033","unstructured":"WHO. Report of the Third Meeting of the WHO Onchocerciasis Technical Advisory Subgroup Geneva, Switzerland, 26\u201328 February 2019. 2020. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240006638."},{"issue":"9","key":"pntd.0010682.ref034","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/aje\/kwz109","article-title":"Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis","volume":"188","author":"LE Coffeng","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"Suppl 5","key":"pntd.0010682.ref035","doi-asserted-by":"crossref","first-page":"S510","DOI":"10.1093\/infdis\/jiz674","article-title":"Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring","volume":"221","author":"JID Hamley","year":"2020","journal-title":"J Infect Dis"},{"key":"pntd.0010682.ref036","unstructured":"WHO. Report of the 1st Meeting of the WHO Onchocerciasis Technical Advisory Subgroup, Geneva, Switzerland, 10\u201312 October 2017. 2018. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/273705\/WHO-CDS-NTD-PCT-2018.05-eng.pdf."},{"issue":"5","key":"pntd.0010682.ref037","doi-asserted-by":"crossref","first-page":"e0010380","DOI":"10.1371\/journal.pntd.0010380","article-title":"Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy.","volume":"16","author":"L Djune-Yemeli","year":"2022","journal-title":"PLoS Negl Trop Dis"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0010682","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000}},{"DOI":"10.1371\/journal.pntd.0011505","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T03:29:58Z","timestamp":1700882998000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010682"}},"subtitle":[],"editor":[{"given":"Mar\u00eda-Gloria","family":"Bas\u00e1\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0010682","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]}}}